Diet-Induced Metabolic Improvements in a Hamster Model of Hypercholesterolemia Are Strongly Linked to Alterations of the Gut Microbiota

Department of Food Science and Technology, University of Nebraska, Lincoln, 68583-0919, USA.
Applied and Environmental Microbiology (Impact Factor: 3.67). 06/2009; 75(12):4175-84. DOI: 10.1128/AEM.00380-09
Source: PubMed


The mammalian gastrointestinal microbiota exerts a strong influence on host lipid and cholesterol metabolism. In this study, we have characterized the interplay among diet, gut microbial ecology, and cholesterol metabolism in a hamster model of hypercholesterolemia. Previous work in this model had shown that grain sorghum lipid extract (GSL) included in the diet significantly improved the high-density lipoprotein (HDL)/non-HDL cholesterol equilibrium (T. P. Carr, C. L. Weller, V. L. Schlegel, S. L. Cuppett, D. M. Guderian, Jr., and K. R. Johnson, J. Nutr. 135:2236-2240, 2005). Molecular analysis of the hamsters' fecal bacterial populations by pyrosequencing of 16S rRNA tags, PCR-denaturing gradient gel electrophoresis, and Bifidobacterium-specific quantitative real-time PCR revealed that the improvements in cholesterol homeostasis induced through feeding the hamsters GSL were strongly associated with alterations of the gut microbiota. Bifidobacteria, which significantly increased in abundance in hamsters fed GSL, showed a strong positive association with HDL plasma cholesterol levels (r = 0.75; P = 0.001). The proportion of members of the family Coriobacteriaceae decreased when the hamsters were fed GSL and showed a high positive association with non-HDL plasma cholesterol levels (r = 0.84; P = 0.0002). These correlations were more significant than those between daily GSL intake and animal metabolic markers, implying that the dietary effects on host cholesterol metabolism are conferred, at least in part, through an effect on the gut microbiota. This study provides evidence that modulation of the gut microbiota-host metabolic interrelationship by dietary intervention has the potential to improve mammalian cholesterol homeostasis, which has relevance for cardiovascular health.

Download full-text


Available from: Jens Walter,
1 Follower
38 Reads
  • Source
    • "The major purpose of our work was to try to evaluate potential changes in the gut microbiota that could be due to the hypolipidemic treatment. Numerous studies have proposed that gut microbiota participates in the regulation of cholesterol metabolism [11] [13] [27]. Changing gut microbiota composition, mainly in favor of Bifidobacterium spp., led to an inhibition of the cholesterol synthesis pathway [13]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hypolipidemic drugs are prescribed in the most of cases for the treatment of cardiovascular diseases. Several studies have been showed that the gut microbiota is able to regulate the host cholesterol metabolism. This study aimed to investigate the potential impact of hypolipidemic drugs on the gut microbiota in mice, and to correlate it to the regulation of cholesterol metabolism. Male C57Bl6J mice were divided in four groups fed either a control diet alone (CT), or supplemented with simvastatin (0,1% w/w, Zocor®, MSD), or ezetimibe (0,021% w/w, Ezetrol®, MSD) or a combination of simvastatin and ezetimibe (0,1% and 0,021%, respectively) for one week. The combination of ezetimibe and simvastatin is required to observe a drop in cholesterolemia, linked to a huge activation of hepatic SREBP-2 and the consequent increased expression of genes involved in LDL cholesterol uptake and cholesterol synthesis. The gut microbiota analysis revealed no change in total bacteria, and in major gram positive and gram negative bacteria, but a selective significant increase in Lactobacillus spp. in mice treated with the ezetimibe and decrease by the combination. The changes in lactobacilli level observed ezetimibe or combination treated-mice are negatively correlated to expression of genes related to cholesterol metabolism. The present study showed that ezetimibe taken alone is able to modify the composition of gut microbiota in favor of Lactobacillus spp. These results suggest that members of genus Lactobacillus play an important role in cholesterol metabolism, even in normocholesterolemic mouse model. Copyright © 2015. Published by Elsevier Inc.
    Life sciences 04/2015; 132. DOI:10.1016/j.lfs.2015.04.004 · 2.70 Impact Factor
  • Source
    • "Using this, we can sequence hundreds of samples with depth that cannot be attained by the traditional Sanger-based clone library. It has been used to understand the microbial system in various environments (Sogin et al., 2006; Ley et al., 2008; Martinez et al., 2009; Benson et al., 2010). Additionally, probe-based techniques like fluorescent in situ hybridization (FISH) allow rapid visualization of the organism's bacterial communities (Gottlieb et al., 2008; Pandey et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dialeurolonga malleswaramensis Sundararaj (Hemiptera: Aleyrodidae) is a phytophagous sap sucking insect. It infests Polyalthia longifolia, an important avenue tree of India, effective in alleviating noise pollution and having immense medicinal importance. Samples of this insect were collected from Polyalthia longifolia. The cytochrome c oxidase subunit I gene (mtCO1) helped in the molecular characterization of the insect. The present study reports the bacterial diversity in D. malleswaramensis adults by high throughput 16S rDNA amplicon pyrosequencing. The major genera identified were Portiera and Arsenophonus. Other bacterial genera detected were uncultured alpha proteobacterium, Sphingopyxis and Methylobacterium. We also employed fluorescence in situ hybridization (FISH) in whole mount samples to confirm the presence of dominant endosymbionts Portiera and Arsenophonus to the bacteriocyte of D. malleswaramensis. This study concludes that combining techniques like 16S rDNA amplicon pyrosequencing and FISH reveal both dominant and rare bacteria. The data also predicts the evolutionary position of this pest with respect to other whitefly species using a mitochondrial marker. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Insect Science 03/2015; DOI:10.1111/1744-7917.12220 · 2.14 Impact Factor
  • Source
    • "and Enterococcus spp. which are known for their anti-inflammatory, immunoregulatory and cholesterol lowering properties through production of short chain fatty acids [5,6]. The most biologically relevant compounds contributing to the sensory and nutritional aspects of olives and olive oil are oleuropein, hydroxytyrosol, quercetin, ferulic acid, caffeic acid, p-hydroxybenzoic acid, protocatechuic acid, 3,4-dyhydroxyphenylacetic acid (3,4-DHPA), homovanillic acid and vanilethanediol, whose metabolic and transcriptional profiling has been recently evaluated during fruit development [7]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background The aim of the present work was to evaluate the antibacterial effect of 3,4-DHPEA-EA (methyl-4-(2-(3,4-dihydroxyphenethoxy)-2-oxoethyl)-3-formyl-2-methyl-3,4-dihydro-2H-pyran-5-carboxylate), a derivate of oleuropein, against a range of Gram-positive bacteria, including ATCC strains, food and clinical isolates. Methods The minimum inhibitory concentrations (MICs) of 3,4-DHPEA-EA were determined by the broth microdilution method and the Bioscreen C. Results 3,4-DHPEA-EA was effective against ATCC and clinical isolates of Staphylococcus aureus (MIC values between 125 and 250 μg/ml) and ATCC and clinical isolates of Staphylococcus epidermidis (MIC values between 7.81 and 62.5 μg/ml). No significant differences were observed between the two solvents (methanol and DMSO) used to dissolve 3,4-DHPEA-EA. Conclusions The results obtained could be used to develop novel therapies for the treatment of skin infections. Further studies need to be performed to elucidate the formation of 3,4-DHPEA-EA by acid hydrolysis of oleuropein in the human stomach.
    Annals of Clinical Microbiology and Antimicrobials 07/2014; 13(1):24. DOI:10.1186/1476-0711-13-24 · 2.19 Impact Factor
Show more